Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Ophthalmology
- Publicado em
- 9 dez 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial
Jeremy J Hoffman, Reena Yadav, Sandip D Sanyam, Pankaj Chaudhary, Abhishek Roshan, Sanjay K Singh, Sanjay K Singh, Sailesh K Mishra, Simon Arunga, Victor H Hu et al.
Descritores MeSH
- Keratitis
- Eye Infections, Fungal
- Mycoses
- Corneal Ulcer
- Humans
- Nepal
- Natamycin
- Treatment Outcome
- Adult
- Voriconazole
Veja também
Estudos relacionados
- Antifungal Therapy for Fusarium Keratitis : A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Comparative Evaluation of Topical Monotherapy (Natamycin or Natasol) and Combination Therapy (Natamycin and Voriconazole) in Mild-Moderate Fungal Keratitis
- Temporary Conjunctival Flap Plus Medical Treatment Versus Medical Treatment Only for High-Risk Fungal Keratitis: A Randomized Controlled Trial
- Impact of biofilm formation in fungal corneal ulcers on treatment outcomes: a systematic review and meta-analysis